Skip to main content
. 2012 Oct 29;52(4):711–718. doi: 10.3109/0284186X.2012.731524

Table I.

Characteristics for use of tube feeding (TF) at the start and the end of radiotherapy (RT) (n = 712).

Start RT, n (%)
End RT, n (%)
Characteristics Use of TF No TF P* Missing Use of TF No TF P* Missing
Age
 < 65 years
 ≥ 65 years
36 (8.2)
40 (14.9)
403 (91.8)
228 (85.1)
0.006
5
200 (48.0)
135 (53.6)
217 (52.0)
117 (46.4)
0.175
43
Sex
 Male
 Female
60 (11.4)
16 (8.8)
465 (88.6)
166 (91.2)
0.405
5
249 (50.3)
86 (49.4)
246 (49.7)
88 (50.6)
0.860
43
Site
 Oropharynx
 Larynx
 Hypopharynx
 Oral cavity
23 (6.7)
11 (7.4)
30 (25.4)
12 (12.6)
322 (93.3)
138 (92.6)
88 (74.6)
83 (87.4)
< 0.001
5
161 (48.8)
53 (38.4)
75 (66.4)
46 (52.3)
169 (51.2)
85 (61.6)
38 (33.6)
42 (47.7)
< 0.001
43
Clinical stage
 I
 II
 III
 IV
1 (3.3)
5 (5.4)
17 (8.7)
53 (13.6)
29 (96.7)
87 (94.6)
178 (91.3)
337 (86.4)
0.041
5
13 (43.3)
37 (41.1)
89 (48.4)
196 (53.7)
17 (56.7)
53 (58.9)
95 (51.6)
169 (46.3)
0.134
43
Treatment modality
 CF
 AF
35 (9.8)
41 (11.7)
322 (90.2)
309 (88.3)
0.467
5
126 (38.3)
209 (61.5)
203 (61.7)
131 (38.5)
< 0.001
43
BMI
 Underweight
 Normal weight
 Overweight/obese
8 (18.2)
13 (9.3)
5 (2.9)
36 (81.8)
127 (90.7)
170 (97.1)
0.001
353
25 (62.5)
60 (45.1)
67 (40.1)
15 (37.5)
73 (54.9)
100 (59.9)
0.041
372
Karnofsky
 < 80
 ≥ 80
19 (33.3)
50 (8.1)
38 (66.7)
565 (91.9)
< 0.001
40




Swallowing problem
 Yes
 No
52 (53.1)
24 (3.9)
46 (46.9)
585 (96.1)
< 0.001
5
322 (62.8)
11 (7.1)
191 (37.2)
143 (92.9)
< 0.001
45
Mucositis
 Yes
 No




295 (51.7)
30 (35.7)
276 (48.3)
54 (64.3)
0.007
57
Use of opioid analgesics
 Yes
 No
29 (39.2)
47 (7.4)
45 (60.8)
584 (92.6)
< 0.001 7 217 (66.8)
116 (34.0)
108 (33.2)
225 (66.0)
< 0.001 46
Number of patients, n (%) 76 (10.7) 631 (88.6) 5 (0.7%) 335 (47.1) 334 (46.9) 43 (6.0)

*p-value controlled by Fisher's Exact Test; Data not recorded at that time point; Underweight: BMI < 20 (BMI < 22 if ≥ 70 years); normal weight: BMI 20–25 (BMI 22–27 if ≥ 70years); overweight/obese: BMI > 25 (BMI > 27 if ≥ 70 years).